HT
PRVB

HAP Trading’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

HAP Trading’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,100
Closed -$152K – 1452
2023
Q1 		$152K Sell
11,100
-30,900
-74% -$388K 0.02% 344
2022
Q4 		$97K Buy
42,000
+3,800
+10% +$30.7K 0.01% 582
2022
Q3 		$31K Buy
+38,200
New +$174K ﹤0.01% 1105
2022
Q1 		– Sell
-32,500
Closed -$8K – 2951
2021
Q4 		$8K Buy
32,500
+17,400
+115% +$110K ﹤0.01% 2130
2021
Q3 		$8K Buy
15,100
+5,000
+50% +$32.1K ﹤0.01% 2087
2021
Q2 		$11K Sell
10,100
-7,600
-43% -$61.3K ﹤0.01% 1984
2021
Q1 		$23K Buy
+17,700
New +$249K ﹤0.01% 1424
2020
Q4 		– Sell
-10,500
Closed -$35K – 2473
2020
Q3 		$35K Sell
10,500
-10,700
-50% -$135K ﹤0.01% 1045
2020
Q2 		$8K Buy
+21,200
New +$268K ﹤0.01% 1492

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HAP Trading's PRVB Position: Q2 2022 in Review

HAP Trading sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2022, closing a stake of 37,539 shares — an estimated $178K sold.

HAP Trading first reported a position in PRVB in Q1 2022 and held it in 1 quarter. The position peaked at $275K in Q1 2022. 115 funds tracked by Wall St. Rank hold PRVB as of Q2 2022.

  • HAP Trading reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 37,539 Provention Bio, Inc. Common Stock shares in Q2 2022, an estimated $178K.
  • HAP Trading first reported a position in Provention Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • HAP Trading's Provention Bio, Inc. Common Stock position peaked at $275K in Q1 2022.
  • 115 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.